Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Cymene SCHEMBL4860410 | 0.94 | ACHE (0.50) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL29006180 | 0.94 | ACHE (0.50) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL3684076 | 0.94 | ACHE (0.50) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL2570692 | 0.92 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL6510505 | 0.92 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL6274941 | 0.92 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL4005540 | 0.92 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL30626114 | 0.92 | ACHE (0.47) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL1143 | 0.91 | ACHE (0.53) | ACHETDP1CHRNA7BCHETYR | |
| P-Cymene SCHEMBL1697748 | 0.91 | ACHE (0.53) | ACHETDP1CHRNA7BCHETYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8471018-B2 | Photosensitizer and photovoltaic device | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20110108117-A1 | PHOTOSENSITIZER AND PHOTOVOLTAIC DEVICE | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2262049-A1 | NOVEL PHOTOSENSITIZER AND PHOTOVOLTAIC ELEMENT | JX Nippon Oil & Energy Corporation (JP) | 2010-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110108117-A1 | PHOTOSENSITIZER AND PHOTOVOLTAIC DEVICE | CRY2, MLX, MLEC | ACHE 3107/4885TDP1 4299/4885CHRNA7 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.